Amended Statement of Ownership (sc 13g/a)
February 15 2023 - 01:57PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Amendment No. 1)
Under the Securities Exchange Act of 1934
THERAPEUTIC SOLUTIONS
INTERNATIONAL, INC.
|
(Name
of Issuer)
|
|
COMMON STOCK
|
(Title
of Class of Securities)
|
|
883378101
|
(CUSIP
Number)
|
|
December 31, 2022
|
(Date
of Event Which Requires Filing of this Statement)
|
Check
the appropriate box to designate the rule pursuant to which this
Schedule is filed:
☐Rule 13d-1(b)
☒Rule 13d-1(c)
☐Rule 13d-1(d)
*The
remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior
cover page.
The
information required in the remainder of this cover page shall not
be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
Persons who respond to the collection of information contained
in this form are not required to respond unless the form displays a
currently valid OMB control number.
CUSIP No.
883378101
|
13G
|
Page 2
of 5
|
1
|
Name of Reporting Persons
I.R.S. Identification Nos. of above persons (entities
only).
JADI CELL, LLC
EIN: 30-0711202
|
2
|
Check the Appropriate Box if a Member of a Group
(see instructions)
(a) ☐
(b) ☐
|
3
|
SEC Use Only
|
4
|
Citizenship or Place of Organization
Delaware, United States
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person with:
|
5
|
Sole Voting Power
131,402,390
|
6
|
Shared Voting Power
-0-
|
7
|
Sole Dispositive Power
131,402,390
|
8
|
Shared Dispositive Power
-0-
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting
Person
131,402,390
|
10
|
Check Box if the Aggregate Amount in Row (9) Excludes Certain
Shares (see instructions) ☐
|
11
|
Percent of Class Represented by Amount in Row 9
4.95% (based on the total of 2,656,578,599 outstanding shares of
Common Stock)
|
12
|
Type of Reporting Person (see instructions)
OO
|
CUSIP No.
883378101
|
13G
|
Page 3
of 5
|
Item 1
|
(a)
|
Name of Issuer.
|
|
|
Therapeutic Solutions International, Inc., a Nevada corporation
|
|
|
|
|
(b)
|
Address of Issuer’s Principal Executive Offices.
|
|
|
701
Wild Rose Lane
|
|
|
Elk
City, ID 83525
|
|
|
|
Item 2
|
(a)
|
Name of Person Filing.
|
|
|
Jadi
Cell, LLC
|
|
|
|
|
(b)
|
Address of Principal Business Office, or, if none,
Residence.
|
|
|
1100
Biscayne Blvd.
|
|
|
Miami, FL 33132
|
|
|
|
|
(c)
|
Citizenship or Place of Organization.
|
|
|
Delaware
|
|
|
|
|
(d)
|
Title of Class of Securities.
|
|
|
Common stock, par value $0.001 per share (the “Common Stock”).
|
|
|
|
|
(e)
|
CUSIP Number.
|
|
|
883378101
|
Item 3
|
If
this statement is filed pursuant to §240.13d-1(b) or 240.13d-2(b)
or (c), check whether the person filing is a:
|
|
|
|
|
|
(a)
|
☐
|
Broker or dealer registered under section 15 of the Act (15 U.S.C.
78o);
|
|
|
|
|
|
(b)
|
☐
|
Bank
as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
|
|
|
|
|
(c)
|
☐
|
Insurance company as defined in section 3(a)(19) of the Act (15
U.S.C. 78c);
|
|
|
|
|
|
(d)
|
☐
|
Investment company registered under section 8 of the Investment
Company Act of 1940 (15 U.S.C 80a-8);
|
|
|
|
|
|
(e)
|
☐
|
An
investment adviser in accordance with
§ 240.13d-1(b)(1)(ii)(E);
|
|
|
|
|
|
(f)
|
☐
|
An
employee benefit plan or endowment fund in accordance with
§ 240.13d-1(b)(1)(ii)(F);
|
|
|
|
|
|
(g)
|
☐
|
A
parent holding company or control person in accordance with
§ 240.13d-1(b)(1)(ii)(G);
|
|
|
|
|
|
(h)
|
☐
|
A
savings associations as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
|
|
|
(i)
|
☐
|
A
church plan that is excluded from the definition of an investment
company under section 3(c)(14) of the Investment Company Act of
1940 (15 U.S.C. 80a-3);
|
|
|
|
|
|
(j)
|
☐
|
A
non-U.S. institution in accordance with
§ 240.13d-1(b)(1)(ii)(J);
|
|
|
|
|
|
(k)
|
☐
|
Group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing
as a non-U.S. institution in accordance with
§ 240.13d-1(b)(1)(ii)(J), please specify the type of
institution: ____
|
CUSIP No.
883378101
|
13G
|
Page 4
of 5
|
Item 4
|
Ownership.
|
|
|
|
|
(a)
|
Amount beneficially owned: 131,402,390.
|
|
|
|
|
(b)
|
Percent of class: 4.95%.
|
|
|
|
|
(c)
|
Number of shares as to which the person has:
|
|
|
|
|
|
(i) Sole power to vote or to direct the vote:
131,402,390
|
|
|
|
|
|
(ii) Shared power to vote or to direct the vote:
|
|
|
|
|
|
(iii) Sole power to dispose or to direct the disposition of:
131,402,390
|
|
|
|
|
|
(iv) Shared power to dispose or to direct the disposition
of:
|
|
|
Item 5
|
Ownership of Five Percent or Less of a Class.
|
|
|
|
If
this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check
the following ☒.
|
|
|
Item 6
|
Ownership of More Than Five Percent on Behalf of Another
Person.
|
|
|
|
Inapplicable.
|
|
|
Item 7
|
Identification and Classification of the Subsidiary which
Acquired the Security Being Reported On by the Parent Holding
Company.
|
|
|
|
Inapplicable.
|
|
|
Item 8
|
Identification and Classification of Members of the
Group.
|
|
|
|
Inapplicable.
|
|
|
Item 9
|
Notice of Dissolution of Group.
|
|
|
|
Inapplicable.
|
|
|
Item 10
|
Certification.
|
|
|
|
By
signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
|
CUSIP No.
883378101
|
13G
|
Page 5
of 5
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement
is true, complete and correct.
February 15, 2023
JADI CELL, LLC
/s/ Amit Patel
Name: Amit Patel
Title: Manager
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From May 2023 to Jun 2023
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Jun 2022 to Jun 2023